HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of Regularly Scheduled Ibuprofen Versus "Pro Re Nata" for Ankle Sprains in Children Treated in the Emergency Department: A Randomized Controlled Trial.

AbstractOBJECTIVE:
We compared pain and degree of disability in patients with acute ankle sprains receiving regular scheduled ibuprofen versus pro re nata (PRN).
METHODS:
This study is a randomized single-blinded controlled trial of children aged 7 to 17 years presenting with acute ankle sprain to an emergency department. Patients were randomized to receive 10 mg/kg of ibuprofen per dose (maximum 600 mg) every 6 hours regular scheduled versus PRN. Outcome measures included a 100-mm visual analog scale pain and degree of disability at day 4. A sample size of 72 children had a power of 80% to detect a clinically meaningful difference of 20 mm between the regular and PRN group.
RESULTS:
We randomly assigned 99 patients to receive regular scheduled (n = 50) or PRN (n = 49) ibuprofen. Pain scores and degree of disability at day 4 showed no significant differences between groups. The rate of reported adverse effects was higher in the regular scheduled group (11.4% vs 9.5%) versus the PRN group.
CONCLUSIONS:
Our study suggests that there is little benefit from routinely using a regular scheduled ibuprofen regimen for acute pediatric ankle sprains.
AuthorsRodrick Lim, Gurinder Sangha, Natasha Lepore, Katelyn M Bartlett, Jamie A Seabrook, Michael Rieder
JournalPediatric emergency care (Pediatr Emerg Care) Vol. 36 Issue 12 Pg. 559-563 (Dec 2020) ISSN: 1535-1815 [Electronic] United States
PMID33060555 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Ibuprofen
Topics
  • Adolescent
  • Ankle Injuries (drug therapy)
  • Child
  • Double-Blind Method
  • Emergency Service, Hospital
  • Humans
  • Ibuprofen (therapeutic use)
  • Outcome Assessment, Health Care
  • Pain Measurement
  • Sprains and Strains (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: